SCHEMBL440073

SCHEMBL440073

CCNC(=O)NCCCOCCOCCOCCCNC(=O)NC(COCCC(=O)OC)(COCCC(=O)OC)COCCC(=O)OC

nearest known ligand 0.38

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 13/20 0.38
MAPT P10636 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TSHR P16473 1/20 0.36
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL436883 0.88 TSHR (0.38) EPHX2TSHRLMNA
SCHEMBL469121 0.86 EPHX2 (0.33) EPHX2MAPTHSD17B10TSHR
SCHEMBL12723360 0.78 ALDH1A1 (0.51) EPHX2MAPTTSHRLMNA
SCHEMBL13656827 0.77 MAPT (0.54) MAPTHSD17B10LMNA
SCHEMBL14035644 0.76 EPHX2 (0.36) EPHX2LMNA
SCHEMBL24136313 0.74 TSHR (0.37) TSHR
SCHEMBL17089355 0.73 HDAC3 (0.37)
SCHEMBL19509699 0.72 TSHR (0.37) TSHRLMNA
SCHEMBL437902 0.72 SMN1; SMN2 (0.44) HSD17B10
SCHEMBL17089346 0.72 TSHR (0.31) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9139456-B2 Chelating compounds and immobilized tethered chelators THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) 2015-09-22 US disclosed
US-9139456-B2 Chelating compounds and immobilized tethered chelators THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) 2015-09-22 US disclosed
US-20120061325-A1 CHELATING COMPOUNDS AND IMMOBILIZED TETHERED CHELATORS THE CURATORS OF THE UNIVERSITY OF MISSOURI 2012-03-15 US disclosed
US-20120061325-A1 CHELATING COMPOUNDS AND IMMOBILIZED TETHERED CHELATORS THE CURATORS OF THE UNIVERSITY OF MISSOURI 2012-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120061325-A1 CHELATING COMPOUNDS AND IMMOBILIZED TETHERED CHELATORS BTD, TTPA, SLC39A7 EPHX2 3551/4885MAPT 2716/4885HSD17B10 4580/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.